No Picture
News

Halozyme Therapeutics, Inc. Announces Proposed Offering of $400 Million of Convertible Senior Notes due 2024

SAN DIEGO, Nov. 12, 2019 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (the “Company”), a biotechnology company focused on novel biological and drug delivery approaches, today announced that it intends to offer, subject to market condit… […]

No Picture
News

Neurocrine Biosciences Publishes Long-Term INGREZZA® (valbenazine) Data in the Journal of Clinical Psychopharmacology Demonstrating Once-Daily 40 mg and 80 mg Capsules Reduced Involuntary Movements in Adults with Tardive Dyskinesia

– Approximately 90% of Patients Treated with INGREZZA in the Open-Label KINECT 4 Phase III Study Achieved a 50% or Greater Improvement in Their Tardive Dyskinesia Symptoms- INGREZZA Continues to Be Well Tolerated Through One Year of Treatment

SAN D… […]

News

San Diego Angel Conference

The San Diego Angel Conference takes place March 28, 2020. At this conference at least one company will be selected as the winner of a pitch contest to receive angel funding from a fund capped at $1,000,000.
 
The process begins in December with applic… […]

No Picture
News

AttackIQ Joins New Collaborative Research Program to Advance Understanding of Cyber Adversaries and Improve the Effectiveness of Defenses Against Cyber Attacks

SAN DIEGO–(BUSINESS WIRE)–AttackIQ?, the leading independent vendor of continuous security validation solutions, today announced the company has joined a new research group formed by MITRE Engenuity called the Center for Threat-Informed Defense. Atta… […]